Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$0.64 - $3.15 $65,371 - $321,750
-102,143 Reduced 50.78%
99,010 $69,000
Q4 2022

Feb 13, 2023

BUY
$2.03 - $4.28 $61,720 - $130,129
30,404 Added 17.81%
201,153 $455,000
Q3 2022

Nov 14, 2022

BUY
$3.04 - $5.14 $2,863 - $4,841
942 Added 0.55%
170,749 $546,000
Q2 2022

Aug 15, 2022

BUY
$3.17 - $6.17 $33,922 - $66,025
10,701 Added 6.73%
169,807 $645,000
Q1 2022

May 12, 2022

BUY
$4.16 - $13.72 $81,606 - $269,145
19,617 Added 14.06%
159,106 $858,000
Q4 2021

Feb 11, 2022

BUY
$10.83 - $18.41 $853,035 - $1.45 Million
78,766 Added 129.71%
139,489 $1.88 Million
Q3 2021

Nov 10, 2021

SELL
$13.07 - $18.84 $143 - $207
-11 Reduced 0.02%
60,723 $1.09 Million
Q2 2021

Aug 12, 2021

SELL
$16.52 - $20.4 $710 - $877
-43 Reduced 0.07%
60,734 $1.04 Million
Q1 2021

May 12, 2021

BUY
$16.56 - $25.46 $14,390 - $22,124
869 Added 1.45%
60,777 $1.22 Million
Q4 2020

Feb 12, 2021

BUY
$15.77 - $19.03 $40,528 - $48,907
2,570 Added 4.48%
59,908 $1.02 Million
Q3 2020

Nov 12, 2020

BUY
$16.59 - $24.79 $326,524 - $487,916
19,682 Added 52.27%
57,338 $951,000
Q2 2020

Aug 11, 2020

SELL
$16.86 - $23.44 $62,921 - $87,478
-3,732 Reduced 9.02%
37,656 $872,000
Q1 2020

May 14, 2020

BUY
$14.47 - $27.96 $149,894 - $289,637
10,359 Added 33.38%
41,388 $739,000
Q4 2019

Feb 11, 2020

BUY
$15.87 - $23.12 $314,178 - $457,706
19,797 Added 176.26%
31,029 $670,000
Q3 2019

Nov 14, 2019

BUY
$16.91 - $36.27 $16,893 - $36,233
999 Added 9.76%
11,232 $205,000
Q2 2019

Aug 13, 2019

BUY
$31.0 - $36.3 $1,674 - $1,960
54 Added 0.53%
10,233 $364,000
Q1 2019

May 07, 2019

BUY
$31.58 - $46.35 $23,274 - $34,159
737 Added 7.81%
10,179 $342,000
Q4 2018

Feb 11, 2019

SELL
$30.43 - $56.65 $143,355 - $266,878
-4,711 Reduced 33.29%
9,442 $310,000
Q3 2018

Nov 08, 2018

SELL
$46.46 - $68.49 $126,045 - $185,813
-2,713 Reduced 16.09%
14,153 $863,000
Q2 2018

Aug 03, 2018

BUY
$46.25 - $104.45 $114,052 - $257,573
2,466 Added 17.13%
16,866 $824,000
Q1 2018

May 09, 2018

BUY
$57.4 - $108.44 $826,560 - $1.56 Million
14,400 New
14,400 $1.53 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.